Ameriprise’s SomaLogic, Inc. Warrant SLGCW Stock Holding History

Ameriprise’s Portfolio SLGCW Stock Details SLGCW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-143,707	Closed	-$496K	–	4065
2021 Q3	$496K	Buy	+143,707	New	+$443K	﹤0.01%	3410

Other funds holding SLGCW

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Walleye Capital New York $24B AUM 37.67% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Dendur Capital New York $1.36B AUM 38.43% 1-Year Est. Return

PVI

Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return

Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return

LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return

FBCM

Fort Baker Capital Management Larkspur, California $1.27B AUM 25.46% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Ameriprise's SLGCW Position: Q4 2021 in Review

Ameriprise sold out of SomaLogic, Inc. Warrant (SLGCW) in Q4 2021, closing a stake of 143,707 shares — an estimated $496K sold.

Ameriprise first reported a position in SLGCW in Q3 2021 and held it in 1 quarter. The position peaked at $496K in Q3 2021. 34 funds tracked by Wall St. Rank hold SLGCW as of Q4 2021.

Ameriprise reported no remaining SomaLogic, Inc. Warrant position as of Q4 2021 after selling out during the quarter.
Ameriprise sold 143,707 SomaLogic, Inc. Warrant shares in Q4 2021, an estimated $496K.
Ameriprise first reported a position in SomaLogic, Inc. Warrant in Q3 2021 and held it in 1 quarter.
Ameriprise's SomaLogic, Inc. Warrant position peaked at $496K in Q3 2021.
34 funds tracked by Wall St. Rank held SomaLogic, Inc. Warrant as of Q4 2021.

Based on Ameriprise's 13F filing for Q4 2021, filed 14 Feb 2022.